Leytin V, Mody M, Semple J W, Garvey B, Freedman J
Departments of Transfusion Medicine and Laboratory Medicine and Pathobiology, St. Michael's Hospital and University of Toronto, Toronto, Canada.
Biochem Biophys Res Commun. 2000 Mar 5;269(1):85-90. doi: 10.1006/bbrc.2000.2255.
Two flow cytometric parameters are generally used to quantify platelet activation as measured by P-selectin (CD62) expression: percentage and mean channel fluorescence of CD62-positive platelets (%(+) and MCF(+), respectively). We describe a method for calculation of indices of platelet activation for positive (IPA(+)) and total (IPA(Sigma)) platelets, which reflect integrated amounts of CD62 expressed in these populations; IPA(+) is calculated as the product of %(+) and MCF(+), whereas IPA(Sigma) is exclusively determined by mean fluorescence of the total platelet population (MCF(Sigma)) and does not depend on %(+). We use these parameters to characterize human platelet activation in whole blood samples treated with varying human alpha-thrombin concentrations, mimicking the variations in platelet activation in a number of clinical settings. Multiparameter analysis of CD62 expression may be useful for selective diagnosis of disorders with systemic or localized platelet activation and for monitoring the clinical course of the disease and effect of therapeutic interventions.
通常使用两个流式细胞术参数来量化通过P-选择素(CD62)表达测量的血小板活化:CD62阳性血小板的百分比和平均通道荧光(分别为%(+)和MCF(+))。我们描述了一种计算阳性血小板(IPA(+))和总血小板(IPA(Σ))活化指数的方法,这些指数反映了这些群体中CD62的表达总量;IPA(+)计算为%(+)与MCF(+)的乘积,而IPA(Σ)仅由总血小板群体的平均荧光(MCF(Σ))确定,且不依赖于%(+)。我们使用这些参数来表征用不同人α-凝血酶浓度处理的全血样本中的人血小板活化情况,模拟多种临床环境中血小板活化的变化。对CD62表达的多参数分析可能有助于对全身性或局部性血小板活化疾病进行选择性诊断,并监测疾病的临床进程和治疗干预效果。